Medicine Overview of Giran H 8mg+12.5mg Tablet
- Hypertension (high blood pressure)
- Nausea
- Taste change
- Stomach pain
- Diarrhea
- Weakness
- Dizziness
- Headache
- Decreased blood pressure
- Increased blood uric acid
- Electrolyte imbalance
- Glucose intolerance
- Increased blood lipid level
-
You have been prescribed Candelong H 8mg/12.5mg Tablet for the treatment of high blood pressure.
-
It can be taken with or without food.
-
Candelong H 8mg/12.5mg Tablet may cause dehydration. Drink plenty of fluids and inform your doctor if you develop extreme thirst, very dry mouth or muscle weakness.
-
It may cause dizziness. Get up slowly when rising from a sitting or lying position.
-
Use of Candelong H 8mg/12.5mg Tablet during pregnancy or breastfeeding is unsafe.
-
It may also decrease the risk of stroke and heart attacks.
16-32 mg candesartan/12.5-25 mg HCTZ PO: 1 tablet once daily.
Elderly: No dosage adjustment is necessary in elderly patients.
Impaired Hepatic Function: Patients with Hepatic Impairment: Dose titration is recommended in patients with mild to moderate chronic liver disease.
This should not be used in patients with severe hepatic impairment and/or cholestasis.
In patients with mild to moderate renal impairment (ie, creatinine clearance between 30-80 mL/min/1.73m2 BSA), a dose titration is recommended.
This should not be used in patients with severe renal impairment (creatinine clearance <30 mL/min/1.73 m2 BSA).
Hydrochlorothiazide inhibits the reabsorption of Na and chloride in the distal tubules causing increased excretion of Na and water K and hydrogen ions.
Lactation: enters breast milk/contraindicated
Headache (3%),Dizziness (3%),Upper respiratory tract infection (4%),Back pain (3%),Flu-like syndrome (2%)
Frequency Not Defined
Candesartan
Dizziness, headache, vertigo, back pain, upper resp tract infections, pharyngitis, rhinitis, hypotension, hyperkalaemia, increased serum creatinine.
Hydrochlorothiazide
Anorexia,Epigastric distress,Hypotension,Orthostatic hypotension,Photosensitivity,Anaphylaxis,Anemia,Confusion,Erythema multiforme,Stevens-Johnson syndrome,Exfoliative dermatitis including toxic epidermal necrolysis,Dizziness,Headache,Hyperuricemia,Hypokalemia and/or hypomagnesemia
Lactation: enters breast milk/contraindicated
Potentially Fatal: Coadministration w/ aliskiren in diabetic patients may increase risk of renal impairment, hypotension and hyperkalaemia.
Reviews
Clear filtersThere are no reviews yet.